in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Biotech Firm Protéus Awarded U.S. Patent for Protein Engineering
3:58 AM MST | November 10, 2011 | Alex Scott
Protéus (Nîmes, France), a biotech firm recently has been granted a U.S. patent for protein engineering and directed evolution in the manipulation of organisms for making biochemicals. The newly awarded patent U.S. No. 7,923,236 is a counterpart to the company’s existing European patent for the same technology granted in 2010. The patented technology belongs to the firm’s EvoSight protein engineering platform, which also includes the L-Shuffling technology for gene shuffling. The invention provides unprecedented insights...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee